Miller Fisher Syndrome
Neurology
Illness script · Neurology
Miller Fisher Syndrome
Autoimmune GBS variant characterized by the classic triad of ophthalmoplegia, ataxia, and areflexia following a preceding infection.
This illness script for Miller Fisher Syndrome covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.
01
Predisposing factors
- Young to middle-aged adults; slight male predominance
- Preceded by URI (most common) or GI illness, 1–4 weeks prior
- Campylobacter jejuni most common bacterial trigger; also EBV, CMV, H. influenzae
- Represents ~5% of all GBS-spectrum disorders worldwide
- Higher incidence in East Asian populations
02
Presentation
- Classic triad: ophthalmoplegia + gait ataxia + areflexia
- Typically descending onset — diplopia/ptosis appears first
- Gait ataxia disproportionate to limb weakness (limbs often spared)
- Bilateral, relatively symmetric cranial nerve involvement
- Onset peaks 1–4 weeks after preceding infection
- Pupillary reflexes often preserved despite severe ophthalmoplegia
03
Pathophysiology
- Molecular mimicry: microbial antigens resemble GQ1b ganglioside epitopes
- Anti-GQ1b IgG antibodies produced and attack GQ1b-rich sites
- GQ1b highly expressed at extraocular nerve terminals (CN III/IV/VI) and dorsal root ganglia
- Results in demyelination/axonal injury at cranial nerves and cerebellar pathways
04
Diagnostics
- Anti-GQ1b IgG antibodies: >90% sensitive, highly specific — key confirmatory test
- CSF: albuminocytologic dissociation (elevated protein, normal WBC) — same as GBS
- NCS/EMG: reduced or absent sensory nerve action potentials
- MRI brain usually normal — critical to exclude brainstem stroke or Wernicke's
- Clinical diagnosis can precede lab confirmation; do not delay treatment
05
Management
- IVIG (2 g/kg over 5 days) or plasmapheresis — same as classic GBS
- Steroids NOT beneficial and not recommended (as in all GBS variants)
- Generally self-limiting; most recover fully within weeks to months
- Monitor closely for overlap with classic GBS (~25% develop limb weakness)
- Supportive care; mechanical ventilation rarely needed unlike classic GBS
06
Clinical pivots
How to separate this script from the look-alikes that show up on exams and on the wards.
Wernicke Encephalopathy
Wernicke has confusion/altered consciousness and responds to thiamine; MFS has areflexia and positive anti-GQ1b without encephalopathy.
Brainstem stroke
Stroke is acute, asymmetric, and shows focal lesion on MRI; MFS is subacute, symmetric, with normal MRI.
Guillain-Barré Syndrome (classic)
Classic GBS presents with ascending limb weakness/paralysis; MFS lacks significant limb weakness and leads with the ophthalmoplegia-ataxia-areflexia triad.
Botulism
Botulism causes descending paralysis with early pupillary dilation and autonomic dysfunction; MFS typically spares pupils and has anti-GQ1b antibodies.
Keep reading
Full library- Major Depressive DisorderMood disorder characterized by ≥2 weeks of depressed mood and/or anhedonia plus ≥4 additional neurovegetative symptoms causing functional impairment.
- Myocardial InfarctionIrreversible myocardial ischemia causing cardiomyocyte necrosis, most often from acute coronary artery occlusion by thrombus on ruptured atherosclerotic plaque.
Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.